Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Veerhealth Care Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

4 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Veerhealth Care Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Veerhealth Care Q1 net profit jumps 100.00% at Rs 0.24 cr

    12 Aug 2025, 8:10PM The company reported standalone net profit of Rs 0.24 crore for the quarter ended June 30, 2025 as compared to Rs 0.12 crore in the same period last y
  • Veerhealth Care - Results-Financial Results For June 30, 2025

    12 Aug 2025, 5:18PM Please find attached Unaudited Financial Results for the quarter ended 30th June, 2025.
  • Veerhealth Care - Board Meeting Outcome for Outcome Of Board Meeting

    12 Aug 2025, 5:13PM Please find attached Outcome of Board Meeting.
  • Veerhealth Care Bags Rs 0.49 Cr Order from Leading Pharmacy Chain

    6 Aug 2025, 2:41PM Veerhealth Care Limited has secured a Rs 0.49 crore order from one of India’s largest pharmacy chains, which operates over 5,000 outlets nationw
  • Veerhealth Care - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    6 Aug 2025, 2:41PM We are enclosing herewith the Press Release on receipt of order from one of India's leading chain of pharmacy for manufacturing and supply of Hair Car
  • Veerhealth Care - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

    5 Aug 2025, 4:10PM We are pleased to inform you that the Company has received an order from one of India's leading chain of pharmacy for manufacturing and supply of Hair
  • Veerhealth Care - Announcement under Regulation 30 (LODR)-Investor Presentation

    4 Aug 2025, 12:12PM Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed Investors Presentation
  • Veerhealth Care - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results Of The Company For T

    1 Aug 2025, 5:16PM Veerhealth Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and
  • Veerhealth Care - Updates

    29 Jul 2025, 3:59PM We are pleased to share a glimpse of our newly renovated and expanded factory, following the successful closure of the USFDA audit. This milestone mar
  • Veerhealth Care - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    25 Jul 2025, 11:16AM We are enclosing herewith the Press Release on receipt of regulatory approval and first commercial order from leading marketplace Company.
  • Veerhealth Care - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

    23 Jul 2025, 5:11PM Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, we wish to inform you that in continuation to our intimation dated 7th July, 2025, Com
  • Veerhealth Care announces execution and receipt of export orders

    22 Jul 2025, 12:23PM Veerhealth Care Limited, under its brand Ayuveer, has announced the commencement and receipt of new export orders following its recent USFDA approval.
  • Veerhealth Care announces execution and receipt of export orders

    22 Jul 2025, 12:20PM Veerhealth Care Limited, under its brand Ayuveer, has announced the commencement and receipt of new export orders following its recent USFDA approval.
  • Veerhealth Care - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    22 Jul 2025, 12:00PM We are enclosing herewith the Press Release on execution and receipt of orders post USFDA approval.
  • Veerhealth Care - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

    21 Jul 2025, 4:50PM Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, we wish to inform you that following the receipt of approval from the United States Fo
  • Veerhealth Care has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025

    10 Jul 2025, 4:50PM As of June 2025, 31.50% is owned by Indian Promoters and 68.50% by Public. <p align=justify> Top five Promoters holding highest number of shares of Ve
  • Veerhealth Care Signs Contract Manufacturing Deal with Leading Marketplace Company; Expects Growth in Revenue and Exports

    9 Jul 2025, 12:00PM Veerhealth Care Limited (BSE: VEERHEALTH), known for its Ayurvedic brand Ayuveer, has announced a Contract Manufacturing Agreement with a leading play
  • Veerhealth Care - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    9 Jul 2025, 11:51AM We are enclosing herewith the Press Release on Contract Manufacturing Agreement with a company having top position in personal care segment on marketp
  • Veerhealth Care - Announcement Under Regulation 30 (LODR) - Contract Manufacturing Agreement With Leading Marketplace Company

    7 Jul 2025, 12:20PM Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, we wish to inform you that company has entered into a strategic Contract Manufacturing
  • Veerhealth Care - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    4 Jul 2025, 4:42PM Pursuant to Regulation 74(5) of the SEBI (DP) Regulations, 2018, please find attached herewith the certificate received from M/s. Purva Sharegistry (I
  • Veerhealth Care - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    17 Jun 2025, 11:29AM We are enclosing herewith the Press Release on successful completion of onboarding process of Ayuveer products on Myntra for purchase.
  • Veerhealth Care - Announcement Under Regulation 30 (LODR) - \Ayuveer\ Products Now Available On Myntra For Purchase

    16 Jun 2025, 12:09PM We are exhilarated to announce that our brand Ayuveer has achieved a significant milestone by having successfully completing the onboarding process on
  • Veerhealth Care posts Q4 net loss of Rs 0.10 cr

    31 May 2025, 10:53AM The company reported standalone net loss during the quarter stood at Rs 0.10 crore as compared to net loss of Rs 0.55 crore in the previous year quart
  • Veerhealth Care - Announcement Under Regulation 30 (LODR) - Appointment Of Internal And Secretarial Auditor

    30 May 2025, 5:28PM Intimation under Regulation 30.
  • Veerhealth Care - Results-Financial Results For March 31, 2025

    30 May 2025, 5:26PM Please find attached Audited Financial Results for the quarter and year ended 31st March, 2025.
  • Veerhealth Care - Board Meeting Outcome for Outcome Of Board Meeting

    30 May 2025, 5:16PM Please find attached Outcome of Board Meeting.
  • Veerhealth Care - Board Meeting Intimation for Consideration And Approval Of Audited Financial Results Of The Company For The

    21 May 2025, 4:58PM Veerhealth Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and
  • Veerhealth Care - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    20 May 2025, 5:34PM We are enclosing herewith the Press Release on Successful closure of USFDA inspection under 21 CFR 20.64(d)(3).
  • Veerhealth Care - Announcement Under Regulation 30 (LODR) - Successful Closure Of USFDA Inspection Under 21 CFR 20.64(D)(3)

    16 May 2025, 4:21PM Company is pleased to announce that USFDA has concluded that their inspection is \closed\ under 21 CFR 20.64(d)(3).\r\n\r\nWith the above audit closur

Key fundamentals

Evaluate the intrinsic value of Veerhealth Care Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 21.8388 21.4327 13.9506 15.7749 16.2336
Liabilities 21.8388 21.4327 13.9506 15.7749 16.2336
Equity 19.9985 9.9992 6.9342 6.9342 6.9342
Gross Profit 0.6109 0.5005 -0.8205 0.0666 0.6787
Net Profit 0.4061 1.582 -0.0736 0.3792 0.3183
Cash From Operating Activities 2.8958 -0.6976 1.8091 1.004 -0.3559
NPM(%) 3.07 11.91 -0.76 3.58 2.71
Revenue 13.2232 13.2733 9.6261 10.5798 11.7279
Expenses 12.6123 12.7728 10.4466 10.5132 11.0492
ROE(%) 1.85 7.24 -0.33 1.73 1.45

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Veerhealth Care Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Sugal and Damani Share Brokers Ltd 109.55 4.98 12.80 13.61 75.99 0.00
360 One Wam Ltd 1018.00 -2.27 39.01 781.33 2509.50 0.00
Arman Holdings Ltd 100.00 2.65 0.00 11.34 -0.29 0.00
Asia Capital Ltd 17.37 4.95 24.46 6.73 9.71 0.00

Company Info

2005 -Company has splits its Face value of Shares from Rs 10 to Re 1 2010 -Registered Office of the Company has been shifted To Gala No.6,New Nandu Industrial Estate, Mahakali Caves Road, Andheri (East), Mumbai-400093 2013 -Company has changed its name from Niyati Industries Ltd to Veerhealth Care Ltd. 2014 - Veer Health is proud to announce the introduction of MALTREX V TABLET effective remedy for Dengue & Malaria. 2015 - Veerhealth Care Ltd. MOU with Rajnish Hot Deals Pvt. Ltd. for Developing and Manufacturing Ayurvedic Range of Hair Products. 2017 -The Company has introduced Dantveer Herbal Toothpaste and have successfully started manufacturing at Changodar Factory 2023 -The Company has issued Bonus Shares in the Ratio of 1:1. 2024 -Veerhealth Care announced that the brand Ayuveer's products have successfully completed the onboarding process on Nykaa's mobile application and website.

2005 -Company has splits its Face value of Shares from Rs 10 to Re 1 2010 -Registered Office of the Company has been shifted To Gala No.6,New Nandu Industrial Estate, Mahakali Caves Road, Andheri (East), Mumbai-400093 2013 -Company has changed its name from Niyati Industries Ltd to Veerhealth Care Ltd. 2014 - Veer Health is proud to announce the introduction of MALTREX V TABLET effective remedy for Dengue & Malaria. 2015 - Veerhealth Care Ltd. MOU with Rajnish Hot Deals Pvt. Ltd. for Developing and Manufacturing Ayurvedic Range of Hair Products. 2017 -The Company has introduced Dantveer Herbal Toothpaste and have successfully started manufacturing at Changodar Factory 2023 -The Company has issued Bonus Shares in the Ratio of 1:1. 2024 -Veerhealth Care announced that the brand Ayuveer's products have successfully completed the onboarding process on Nykaa's mobile application and website.

Read More

Parent Organisation

Veerhealth Care Ltd.

Founded

10/07/1992

Managing Director

Mr.Bhavin S Shah

NSE Symbol

NIYATILEASBE

FAQ

The current price of Veerhealth Care Ltd is

The 52-week high for Veerhealth Care Ltd is

The market capitalization of Veerhealth Care Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Veerhealth Care Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Veerhealth Care Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Veerhealth Care Ltd shares.

The CEO of Veerhealth Care Ltd is Mr.Bhavin S Shah, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT